Urano publishes research on targeting TXNIP as a strategy for treating nephrotic syndrome

On August 30, Fumihiko Urano, MD, PhD and colleagues had their research titled “Blocking CHOP-dependent TXNIP shuttling to mitochondria attenuates albuminuria and mitigates kidney injury in nephrotic syndrome,” published in “Proceedings of the National Academy of Sciences of the United States of America.”  Albuminuria is a symptom of glomerular disease and a leading cause of […]